Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

FEBRUARY 21, 2012

Having a strong domestic manufacturing base is vital to the United States maintaining its world leadership in innovation. With the exception of two jet-engine factories and two plants that make heavy equipment, all were located outside the United States. Manufacturing provides the foundation for many kinds of innovations.

Supply Chain 15

Supply Chain Offshoring Engineering Pharmaceuticals 15

Harvard Business Review

OCTOBER 26, 2017

“He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. As with many clusters, a university sits at its center: founded in AD 1088, the Studium of Bologna was the major educational innovation of Europe’s second millennium. How did the city make the leap?

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

FEBRUARY 2, 2015

Science and engineering professionals work closely with experienced technicians to produce next-generation batteries, not forged metal. Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. But just as U.S.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

AUGUST 8, 2012

Of course, we sometimes see such passion in the business world, in the wild enthusiasms of R&D professionals in innovative engineering and pharmaceutical companies. They give new life to the old-fashioned notion that good work gives us good societies.

Pharmaceuticals 15

Pharmaceuticals Wilde Fashion Engineering 15

Harvard Business Review

MARCH 27, 2018

.” But absent “demonstrable harm to competition and consumers,” the DOJ is “reluctant to impose special duties on digital platforms, out of [its] concern that special duties might stifle the very innovation that has created dynamic competition for the benefit of consumers.” ” How Data-opolies Harm.

Company 10

Company Advertising Incentives Engineering 10

Harvard Business Review

NOVEMBER 27, 2013

Recent events have seen a rash of the departures from large corporates: Steve Ballmer from MicroSoft, Jeremy Levin from Teva Pharmaceutical, and Thorsten Heins from Blackberry. After the initial rush of enthusiasm and energy, established routines and networks can smother the drive for innovation. James McNerney, Jr is another example.

CEO 13

CEO Long-term Welch Pharmaceuticals 13

Harvard Business Review

AUGUST 14, 2018

ineffective innovation strategies. 5 Principles for Innovation in Emerging Markets. They operate in an environment where the barriers to entry are relatively low and the focus of competition is on product and business model innovations and service delivery, rather than the most advanced technologies. Related Video.

Competitive Advantage 10

Competitive Advantage Business Model Technology Marketing 10

Harvard Business Review

MARCH 6, 2012

Technological innovation accounted for almost half of U.S. economic growth over the past 50 years, but the country's standing as the world's indisputable innovation leader is now at risk. This challenge has been especially difficult at the entry levels of science and engineering. That requires integrative thinking.

Education 12

Education Creativity How To Pharmaceuticals 12

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products.

Globalization 8

Globalization Supply Chain Pharmaceuticals McKinsey 8

Harvard Business Review

JUNE 16, 2016

The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity. Innovating the Innovation Process. Draetta of IACS has found many of the same issues arise in pharmaceutical research.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

MARCH 2, 2012

has become a Mecca for international scientists, engineers and business students — particularly those undertaking graduate studies. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

APRIL 13, 2012

It's depressing to realize how few of the teams in our lives use their human capital and opportunities well, when it comes to sustaining performance, innovating, or adapting. The drug development team leader at a major pharmaceutical company saw his role as the world-wide leader, not just within his country or therapeutic area.

Team 14

Team Sports Pharmaceuticals PR 14

Harvard Business Review

SEPTEMBER 15, 2014

Consider Ashoka , which provides start-up funding and support for social innovators worldwide. As Linda Hill and her colleagues have described, the company needed expert knowledge as it navigated the technically and ethically challenging waters of pharmaceutical development and marketing.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

MAY 7, 2015

If you’re Amazon, Disney, some of the pharmaceuticals…the markets support their huge long-term investments because they can see where the investments will lead. It’s fashionable to put your engineers onto solving customer problems. So how did you and your co-authors square that circle? It’s great.

Short-term 8

Short-term Henderson Long-term Metrics 8

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. This may all change as China innovates and grows.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

FEBRUARY 10, 2014

Back in 2006, my colleague Huggy Rao and I launched an executive education program at Stanford called “Customer-focused Innovation.” Mornings consisted of lectures and case studies in a traditional classroom in the Stanford Business School; this was the “clean models” part of the program. Scaling starts and ends with individuals.

Case Study 10

Case Study Pharmaceuticals Airlines Hotels 10

Harvard Business Review

SEPTEMBER 5, 2013

So large-scale re-engineering programs, productivity drives, and changes to the incentive system are unlikely to work: they can easily be resisted, ignored or gamed. Marissa Mayer, Yahoo''s CEO, ended the company''s work-from-home policy to foster a more collaborative, innovative environment.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

FEBRUARY 6, 2014

For starters, he will be running a $75 billion+ enterprise with some 100,000 employees, an army of software engineers and many moving parts. Consider the CEO succession process at pharmaceutical giant GlaxoSmithKline beginning in 2004 when chief executive Jean-Pierre Garnier said he would be exiting in three years.

CEO 8

CEO Bottom-up Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

OCTOBER 11, 2013

Four years ago, Craig Hatkoff, co-founder of the Tribeca Film Festival, approached me about a brainstorm: an event recognizing and celebrating breakthrough innovators. When I suggested to Clayton Christensen that we partner with Hatkoff to create the Tribeca Disruptive Innovation Awards , Clay’s response was : I trust you Whitney.

Innovation 10

Innovation Christensen Decisionmaking CTO 10

Harvard Business Review

SEPTEMBER 20, 2011

A vast ideological gap on macro-economic policy divides Washington and much of the nation, but there is almost universal agreement on one solution: innovation. Innovation is now perceived as a panacea for job creation, income generation, economic growth, dollar strength, and the revival of the U.S. as global hegemon.

Innovation 12

Innovation Supply Chain Offshoring Policies 12

Harvard Business Review

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. Some regenerative medicines stimulate our bodies to regrow or repair, so the field can include the use of stem cells for tissue engineering. But the benefits don’t stop there, Novick points out.

Pharmaceuticals 8

Pharmaceuticals Content Licensing Trends 8

Harvard Business Review

JANUARY 23, 2015

The question we asked: How might a shortage of science, technical, engineering, and math (STEM) talent affect the growth of life sciences companies? Here are a few of the provocative ideas the group advanced: Pharmaceutical and biotech firms will make smaller bets, and more of them.

Kahneman 8

Kahneman Scenario Planning Pharmaceuticals Workshop 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. telemetry, communications and connectivity protocols, electrical hardware engineering).

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

NOVEMBER 20, 2015

Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail. Innovate and invest, even when it hurts. Manage culture by setting expectations appropriately.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

NOVEMBER 12, 2018

With dozens of other genetically engineered therapies moving through clinical trials, the long-promised era of personalized, gene-based medicine seemed to be at hand. Our research on major innovations finds that when disruption occurs, technologies don’t replace technologies; systems replace systems. Something has got to give.

Business Model 10

Business Model Insurance Cost Bond 10

Harvard Business Review

NOVEMBER 7, 2012

Innovation is one those evergreen themes: it is a rare CEO who doesn't list innovation as one her top four or five priorities. But innovation is an elusive beast. We can look to companies renowned for innovation — like Apple and Google — and try to learn from them. So what to do? But that's a flawed approach.

Company 8

Company Stage-Gate Innovation Bureaucracy 8

Harvard Business Review

SEPTEMBER 5, 2016

Yet there’s compelling evidence that bureaucracy creates a significant drag on productivity and organizational resilience and innovation. More freedom and responsibility would mean more initiative, innovation, and institutional flexibility — which would further boost productivity. Here’s the arithmetic.

Cost 8

Cost Bureaucracy GDP Management 8

Harvard Business Review

NOVEMBER 21, 2013

Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. Why do some companies choose to patent their innovation while others choose to hide it? Unlike with patents, it is perfectly legal to reverse engineer and copy a trade secret. Is it possible for other companies to reverse engineer it?

Intangible Assets 8

Intangible Assets Merchandising Innovation Pharmaceuticals 8

Harvard Business Review

JUNE 23, 2015

I studied cross-functional teams in industries including communications, software, pharmaceuticals, semiconductors, agricultural, chemical, manufacturers, retail, utility, consulting, internet software, government, insurance, and banking. Cross-functional teams have become ubiquitous because companies need to speed innovations to market.

Team 8

Team Project Software Engineering 8

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., aerospace & defense, construction & engineering, industrial conglomerates, professional services, textiles); IT & Telecommunications (e.g.,

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. This is an incredible moment for innovation.

Innovation 12

Innovation Productivity Products Venture Capitalist 12

Harvard Business Review

SEPTEMBER 11, 2014

Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. In other words, if you are in a high uncertainty industry, you must excel at innovation…or die. Customers Innovation Technology'

Uncertainty 21

Uncertainty Industry Bottom-up Technology 21